The fear of the trading war between the EU and the USA in the pharmaceutical sector at the moment avoided, but the European commission remains vigilant, given that the application of new customs rights is likely.
The fear of the trading war between the EU and the USA in the pharmaceutical sector at the moment avoided, but the European commission remains vigilant, given that the application of new customs rights is likely.